Cardiovascular diseases
Conditions
Interventions
Ischemia :NA
Bleeding :NA
Sponsors
Sixth Medical Center of Chinese People's Liberation Army General Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who have been diagnosed with coronary heart disease and are treated with antiplatelet drugs, including patients (PCI, CABG) before and after surgery.
Exclusion criteria
Exclusion criteria: 1. Patients with systemic active infection; 2. Patients with severe liver and kidney insufficiency (ALT>135mmol/L, Cr>200umol/L) or chronic obstructive pulmonary disease; 3. Patients with obvious bleeding tendency and blood diseases Patients; 4. Patients with malignant tumors and end-stage diseases; 5. The life expectancy of patients is less than 6 months; 6. Patients with heart valve disease or left ventricular aneurysm and other diseases requiring simultaneous surgery; 7. Patients with cerebrovascular disease (currently or 6 months Have had cerebral infarction or cerebral hemorrhage within a month); 8. Participated in the trial drug research recently but failed to complete the primary endpoint or clinically hindered the clinical research endpoint; 9. Have been treated with antithrombotic drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse event rate; | — |
Countries
China
Contacts
Public ContactYe Weihua
Sixth Medical Center of Chinese People's Liberation Army General Hospital
Outcome results
None listed